Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia
ConclusionAurora B kinase was identified to be an active therapeutic target in a broad range of ALL cells. Combination therapy of barasertib and a microtubule-targeting drug is of clinical interest.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Drugs & Pharmacology | Leukemia | Study | Taxotere